AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Elevance Health Inc.

$418.72 +$64.47 (+18.20%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$416.54
Day Range
$413.09$426.39
Year Range
$274.84$436.24
Market Cap
90.81B
AVG Volume
1.46M
Trailing/Forward PE
18.61/14.13
PEG ratio
2.03
Dividend Yield
1.64%
Next Earnings Date
2026-10-21
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0100B200B300B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2201.11B
26 Q1200.41B
25 Q4199.12B
25 Q3194.82B
25 Q2189.25B
25 Q1183.12B
24 Q4176.81B
24 Q3174.01B
24 Q2171.72B
24 Q1171.75B
Net Income (USD) · TTM
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q24.96B
26 Q15.24B
25 Q45.66B
25 Q35.53B
25 Q25.36B
25 Q15.92B
24 Q45.98B
24 Q36.42B
24 Q26.69B
24 Q16.24B
Operating Income (USD) · TTM
02.5B5B7.5B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q27.06B
26 Q17.63B
25 Q48.11B
25 Q38.48B
25 Q28.43B
25 Q18.82B
24 Q48.89B
24 Q39.2B
24 Q29.4B
24 Q19.08B
EBITDA (USD) · TTM
05B10B15B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q28.01B
26 Q18.92B
25 Q49.66B
25 Q310.02B
25 Q29.87B
25 Q110.46B
24 Q410.48B
24 Q310.82B
24 Q211.16B
24 Q110.69B
Cash Flows (USD) · TTM
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q26.29B
26 Q16.45B
25 Q43.17B
25 Q33.77B
25 Q25.34B
25 Q13.67B
24 Q44.55B
24 Q3871M
24 Q2820M
24 Q12.3B
EPS (USD) · TTM
010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q222.5
26 Q123.51
25 Q425.12
25 Q324.46
25 Q223.5
25 Q125.63
24 Q425.61
24 Q327.43
24 Q228.52
24 Q126.46
Expenses (USD) · TTM
02B4B6B8BSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q27.5B
26 Q17.49B
25 Q41.12B
25 Q31.15B
25 Q21.12B
25 Q11.17B
24 Q41.26B
24 Q31.26B
24 Q21.25B
24 Q11.27B
Shares Outstanding (USD) · TTM
-2B02B4BBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELV Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q22.46B
26 Q12.6B
25 Q42.33B
25 Q33.73B
25 Q22.93B
25 Q13B
24 Q42.71B
24 Q31.73B
24 Q22.13B
24 Q12.33B
Dividends (USD)
00.511.52Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
ELV Dividends (USD) by quarter
PeriodDividends (USD)
Sep 261.72
Jun 261.72
Mar 261.72
Dec 251.71
Sep 251.71
Jun 251.71
Mar 251.71
Dec 241.63
Sep 241.63
Jun 241.63
Employee Count
050K100K150K2016201720182019202020212022202320242025
ELV Employee Count by quarter
PeriodEmployee Count
202597.1K
2024104.2K
2023104.9K
2022102.3K
202198.2K
202083.4K
201970.6K
201863.9K
201756K
201653K
PE Ratio
101214161820med 14.58Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV PE Ratio by quarter
PeriodPE Ratio
Sep 2618.38
Sep 2617.89
Aug 2617.32
Aug 2617.59
Aug 2617.58
Aug 2617.31
Jul 2616.5
Jul 2616.58
Jul 2616.38
Jul 2617.5
Jul 2617.57
Jun 2616.61
Jun 2616.33
Jun 2616.99
Jun 2617.47
May 2616.53
May 2616.59
May 2616.51
May 2615.89
May 2615.67
Apr 2614.49
Apr 2612.65
Apr 2612.2
Apr 2611.78
Mar 2611.22
Mar 2611.42
Mar 2611.42
Mar 2611.35
Feb 2612.54
Feb 2613.43
Feb 2613.59
Feb 2613.28
Jan 2614.11
Jan 2615.14
Jan 2615.3
Jan 2615.22
Jan 2614.46
Dec 2514.28
Dec 2513.9
Dec 2514.65
Dec 2513.5
Nov 2513.8
Nov 2513.13
Nov 2513.3
Nov 2512.97
Oct 2512.94
Oct 2513.97
Oct 2514.69
Oct 2514.88
Oct 2514.77
Sep 2513.42
Sep 2513.22
Sep 2513.13
Sep 2513.21
Aug 2513.42
Aug 2513.34
Aug 2513.04
Aug 2512.38
Aug 2511.57
Jul 2512.18
Jul 2511.67
Jul 2513.03
Jul 2513.31
Jun 2514.6
Jun 2514.33
Jun 2514.71
Jun 2515.05
May 2514.69
May 2514.24
May 2515.43
May 2515.48
May 2515.69
Apr 2516.13
Apr 2516.15
Apr 2516.73
Apr 2516.32
Mar 2516.43
Mar 2516.25
Mar 2516.01
Mar 2515.58
Feb 2515.1
Feb 2514.65
Feb 2514.13
Feb 2514.21
Jan 2514.37
Jan 2514.56
Jan 2513.99
Jan 2513.84
Jan 2513.49
Dec 2413.47
Dec 2413.29
Dec 2413.85
Dec 2413.87
Nov 2414.78
Nov 2414.62
Nov 2414.55
Nov 2415.34
Nov 2415.03
Oct 2415.44
Oct 2415.64
Free Cash Flow Yield
0%2%4%6%8%10%med 4.85%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 266.89%
Sep 267.08%
Aug 267.32%
Aug 267.21%
Aug 267.21%
Aug 267.32%
Jul 267.68%
Jul 267.64%
Jul 267.74%
Jul 267.03%
Jul 267%
Jun 267.41%
Jun 267.53%
Jun 267.24%
Jun 267.04%
May 267.44%
May 267.41%
May 267.45%
May 267.74%
May 267.85%
Apr 268.49%
Apr 264.43%
Apr 264.59%
Apr 264.76%
Mar 265%
Mar 264.91%
Mar 264.91%
Mar 264.94%
Feb 264.47%
Feb 264.17%
Feb 264.13%
Feb 264.22%
Jan 264.83%
Jan 264.5%
Jan 264.45%
Jan 264.47%
Jan 264.71%
Dec 254.77%
Dec 254.9%
Dec 254.65%
Dec 255.04%
Nov 254.93%
Nov 255.19%
Nov 255.12%
Nov 255.25%
Oct 255.26%
Oct 254.87%
Oct 256.78%
Oct 256.69%
Oct 256.74%
Sep 257.42%
Sep 257.53%
Sep 257.58%
Sep 257.54%
Aug 257.42%
Aug 257.47%
Aug 257.64%
Aug 258.04%
Aug 258.61%
Jul 258.18%
Jul 258.53%
Jul 254.76%
Jul 254.67%
Jun 254.25%
Jun 254.33%
Jun 254.22%
Jun 254.13%
May 254.23%
May 254.36%
May 254.02%
May 254.01%
May 253.96%
Apr 253.85%
Apr 254.71%
Apr 254.55%
Apr 254.67%
Mar 254.63%
Mar 254.68%
Mar 254.75%
Mar 254.89%
Feb 255.04%
Feb 255.2%
Feb 250.96%
Feb 250.95%
Jan 250.94%
Jan 250.93%
Jan 250.97%
Jan 250.98%
Jan 251.01%
Dec 241.01%
Dec 241.02%
Dec 240.98%
Dec 240.98%
Nov 240.92%
Nov 240.93%
Nov 240.93%
Nov 240.88%
Nov 240.9%
Oct 240.88%
Oct 240.87%
Price to Sales
0.30.40.50.6med 0.43Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price to Sales by quarter
PeriodPrice to Sales
Sep 260.45
Sep 260.44
Aug 260.43
Aug 260.43
Aug 260.43
Aug 260.43
Jul 260.41
Jul 260.41
Jul 260.4
Jul 260.46
Jul 260.46
Jun 260.43
Jun 260.43
Jun 260.44
Jun 260.46
May 260.43
May 260.43
May 260.43
May 260.42
May 260.41
Apr 260.38
Apr 260.36
Apr 260.35
Apr 260.33
Mar 260.32
Mar 260.32
Mar 260.32
Mar 260.32
Feb 260.36
Feb 260.38
Feb 260.39
Feb 260.38
Jan 260.4
Jan 260.43
Jan 260.43
Jan 260.43
Jan 260.41
Dec 250.41
Dec 250.39
Dec 250.42
Dec 250.38
Nov 250.39
Nov 250.37
Nov 250.38
Nov 250.37
Oct 250.37
Oct 250.4
Oct 250.42
Oct 250.42
Oct 250.42
Sep 250.38
Sep 250.37
Sep 250.37
Sep 250.37
Aug 250.38
Aug 250.38
Aug 250.37
Aug 250.35
Aug 250.33
Jul 250.34
Jul 250.33
Jul 250.42
Jul 250.43
Jun 250.47
Jun 250.46
Jun 250.48
Jun 250.49
May 250.47
May 250.46
May 250.5
May 250.5
May 250.51
Apr 250.52
Apr 250.55
Apr 250.57
Apr 250.55
Mar 250.56
Mar 250.55
Mar 250.54
Mar 250.53
Feb 250.51
Feb 250.5
Feb 250.52
Feb 250.52
Jan 250.53
Jan 250.54
Jan 250.52
Jan 250.51
Jan 250.5
Dec 240.5
Dec 240.49
Dec 240.51
Dec 240.51
Nov 240.54
Nov 240.54
Nov 240.54
Nov 240.57
Nov 240.55
Oct 240.57
Oct 240.58
EV/EBITDA
89101112med 10.01Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2610.59
Sep 2610.28
Aug 269.93
Aug 2610.09
Aug 2610.09
Aug 269.92
Jul 269.42
Jul 269.47
Jul 269.35
Jul 269.87
Jul 269.91
Jun 269.35
Jun 269.19
Jun 269.57
Jun 269.85
May 269.3
May 269.34
May 269.29
May 268.93
May 268.79
Apr 268.1
Apr 269.88
Apr 269.61
Apr 269.37
Mar 269.04
Mar 269.15
Mar 269.16
Mar 269.11
Feb 269.81
Feb 2610.33
Feb 2610.42
Feb 2610.24
Jan 2610.13
Jan 2610.7
Jan 2610.79
Jan 2610.74
Jan 2610.32
Dec 2510.22
Dec 2510.02
Dec 2510.43
Dec 259.79
Nov 259.96
Nov 259.59
Nov 259.68
Nov 259.5
Oct 259.49
Oct 2510.05
Oct 2510.17
Oct 2510.27
Oct 2510.21
Sep 259.48
Sep 259.37
Sep 259.32
Sep 259.36
Aug 259.48
Aug 259.43
Aug 259.27
Aug 258.91
Aug 258.47
Jul 258.8
Jul 258.53
Jul 259.52
Jul 259.68
Jun 2510.41
Jun 2510.26
Jun 2510.47
Jun 2510.66
May 2510.46
May 2510.21
May 2510.88
May 2510.91
May 2511.02
Apr 2511.28
Apr 2511.54
Apr 2511.87
Apr 2511.64
Mar 2511.7
Mar 2511.6
Mar 2511.46
Mar 2511.22
Feb 2510.94
Feb 2510.69
Feb 2510.16
Feb 2510.21
Jan 2510.3
Jan 2510.42
Jan 2510.08
Jan 259.99
Jan 259.78
Dec 249.77
Dec 249.66
Dec 249.99
Dec 2410.01
Nov 2410.54
Nov 2410.45
Nov 2410.41
Nov 2410.88
Nov 2410.7
Oct 2410.94
Oct 2411.06
Price/Operating Cashflow
01020304050med 15.82Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2612.22
Sep 2611.9
Aug 2611.51
Aug 2611.69
Aug 2611.69
Aug 2611.51
Jul 2610.97
Jul 2611.03
Jul 2610.89
Jul 2612.06
Jul 2612.11
Jun 2611.45
Jun 2611.26
Jun 2611.71
Jun 2612.04
May 2611.4
May 2611.44
May 2611.38
May 2610.96
May 2610.8
Apr 269.99
Apr 2616.7
Apr 2616.11
Apr 2615.55
Mar 2614.81
Mar 2615.07
Mar 2615.08
Mar 2614.97
Feb 2616.54
Feb 2617.73
Feb 2617.93
Feb 2617.53
Jan 2615.89
Jan 2617.06
Jan 2617.23
Jan 2617.14
Jan 2616.28
Dec 2516.08
Dec 2515.66
Dec 2516.51
Dec 2515.2
Nov 2515.55
Nov 2514.79
Nov 2514.98
Nov 2514.61
Oct 2514.58
Oct 2515.74
Oct 2512.2
Oct 2512.36
Oct 2512.26
Sep 2511.15
Sep 2510.98
Sep 2510.91
Sep 2510.97
Aug 2511.15
Aug 2511.07
Aug 2510.83
Aug 2510.29
Aug 259.61
Jul 2510.11
Jul 259.69
Jul 2515.91
Jul 2516.25
Jun 2517.82
Jun 2517.49
Jun 2517.96
Jun 2518.37
May 2517.93
May 2517.39
May 2518.84
May 2518.9
May 2519.15
Apr 2519.7
Apr 2516.63
Apr 2517.23
Apr 2516.8
Mar 2516.92
Mar 2516.73
Mar 2516.49
Mar 2516.04
Feb 2515.54
Feb 2515.08
Feb 2542.56
Feb 2542.8
Jan 2543.27
Jan 2543.85
Jan 2542.13
Jan 2541.68
Jan 2540.63
Dec 2440.58
Dec 2440.02
Dec 2441.71
Dec 2441.79
Nov 2444.5
Nov 2444.02
Nov 2443.82
Nov 2446.21
Nov 2445.27
Oct 2446.5
Oct 2447.11
Price to Book
11.522.5med 1.93Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price to Book by quarter
PeriodPrice to Book
Sep 262.03
Sep 261.97
Aug 261.91
Aug 261.94
Aug 261.94
Aug 261.91
Jul 261.82
Jul 261.83
Jul 261.81
Jul 262.08
Jul 262.09
Jun 261.98
Jun 261.94
Jun 262.02
Jun 262.08
May 261.97
May 261.98
May 261.97
May 261.89
May 261.87
Apr 261.73
Apr 261.63
Apr 261.57
Apr 261.52
Mar 261.44
Mar 261.47
Mar 261.47
Mar 261.46
Feb 261.61
Feb 261.73
Feb 261.75
Feb 261.71
Jan 261.77
Jan 261.9
Jan 261.92
Jan 261.91
Jan 261.81
Dec 251.79
Dec 251.75
Dec 251.84
Dec 251.69
Nov 251.73
Nov 251.65
Nov 251.67
Nov 251.63
Oct 251.62
Oct 251.75
Oct 251.8
Oct 251.82
Oct 251.8
Sep 251.64
Sep 251.62
Sep 251.61
Sep 251.62
Aug 251.64
Aug 251.63
Aug 251.59
Aug 251.51
Aug 251.41
Jul 251.49
Jul 251.43
Jul 251.81
Jul 251.85
Jun 252.03
Jun 251.99
Jun 252.04
Jun 252.09
May 252.04
May 251.98
May 252.14
May 252.15
May 252.18
Apr 252.24
Apr 252.33
Apr 252.42
Apr 252.36
Mar 252.37
Mar 252.35
Mar 252.31
Mar 252.25
Feb 252.18
Feb 252.11
Feb 252.07
Feb 252.08
Jan 252.1
Jan 252.13
Jan 252.05
Jan 252.02
Jan 251.97
Dec 241.97
Dec 241.94
Dec 242.03
Dec 242.03
Nov 242.16
Nov 242.14
Nov 242.13
Nov 242.24
Nov 242.2
Oct 242.26
Oct 242.29
Elevance Health Inc.
ELV
Stockpicker

Video analysis: ELV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELV

Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

benzinga.com · 10 Sep 2026

Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.

California State Teachers Retirement System Raises Stake in Elevance Health, Inc. $ELV

defenseworld.net · 7 Sep 2026

California State Teachers Retirement System Raises Stake in Elevance Health, Inc. $ELV

California State Teachers Retirement System boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 37,390.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 124,019,670 shares of the company's stock after buying an additional 123,688,863 shares during the quarter. California

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.

247wallst.com · 5 Sep 2026

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.

Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.

Allen Mooney & Barnes Investment Advisors LLC Has $17.94 Million Stock Holdings in Elevance Health, Inc. $ELV

defenseworld.net · 4 Sep 2026

Allen Mooney & Barnes Investment Advisors LLC Has $17.94 Million Stock Holdings in Elevance Health, Inc. $ELV

Allen Mooney and Barnes Investment Advisors LLC cut its stake in Elevance Health, Inc. (NYSE: ELV) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,398 shares of the company's stock after selling 3,218 shares during the quarter.

Beaconlight Capital LLC Takes Position in Elevance Health, Inc. $ELV

defenseworld.net · 31 Aug 2026

Beaconlight Capital LLC Takes Position in Elevance Health, Inc. $ELV

Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

zacks.com · 25 Aug 2026

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.

Is ELV Undervalued? DCF Says Worth $614

gurufocus.com · 25 Aug 2026

Is ELV Undervalued? DCF Says Worth $614

On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to

Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV

defenseworld.net · 24 Aug 2026

Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV

Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.